These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults. Baldwin CM; Keam SJ Drugs; 2009 Jul; 69(10):1373-401. PubMed ID: 19583455 [TBL] [Abstract][Full Text] [Related]
46. The Effect of H Shim YK; Kim N Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310 [TBL] [Abstract][Full Text] [Related]
47. The rationale of acid suppression in the treatment of acid-related disease. Mohamed AH; Hunt RH Aliment Pharmacol Ther; 1994; 8 Suppl 1():3-10. PubMed ID: 7910047 [TBL] [Abstract][Full Text] [Related]
48. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548 [TBL] [Abstract][Full Text] [Related]
49. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. Soll AH JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244 [TBL] [Abstract][Full Text] [Related]
50. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Barozzi N; Tett SE Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158 [TBL] [Abstract][Full Text] [Related]
51. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice? Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678 [TBL] [Abstract][Full Text] [Related]
52. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users]. Shimada T; Yamagata M; Hiraishi H Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531 [TBL] [Abstract][Full Text] [Related]
53. Acid-related disorders in the elderly. Franceschi M; Di Mario F; Leandro G; Maggi S; Pilotto A Best Pract Res Clin Gastroenterol; 2009; 23(6):839-48. PubMed ID: 19942162 [TBL] [Abstract][Full Text] [Related]
54. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication. Tan AC; Hartog GD; Mulder CJ Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610 [TBL] [Abstract][Full Text] [Related]
55. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Targownik LE; Fisher DA; Saini SD Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361 [TBL] [Abstract][Full Text] [Related]
57. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases. Yang X; Li Y; Sun Y; Zhang M; Guo C; Mirza IA; Li YQ Dig Dis Sci; 2018 Feb; 63(2):302-311. PubMed ID: 29282636 [TBL] [Abstract][Full Text] [Related]
58. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease. Tytgat GN Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941 [TBL] [Abstract][Full Text] [Related]
59. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. Huang JQ; Hunt RH Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532 [TBL] [Abstract][Full Text] [Related]